BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Phan T, Nguyen VH, Buettner R, Morales C, Yang L, Wong P, Tsai W, Salazar MD, Gil Z, Diamond DJ, Rabinowitz JD, Rosen S, Melstrom LG. Inhibition of de novo pyrimidine synthesis augments Gemcitabine induced growth inhibition in an immunocompetent model of pancreatic cancer. Int J Biol Sci 2021;17:2240-51. [PMID: 34239352 DOI: 10.7150/ijbs.60473] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Ge P, Luo Y, Chen H, Liu J, Guo H, Xu C, Qu J, Zhang G, Chen H. Application of Mass Spectrometry in Pancreatic Cancer Translational Research. Front Oncol 2021;11:667427. [PMID: 34707986 DOI: 10.3389/fonc.2021.667427] [Reference Citation Analysis]
2 Xie L, Zhou T, Xie Y, Bode AM, Cao Y. Mitochondria-Shaping Proteins and Chemotherapy. Front Oncol 2021;11:769036. [PMID: 34868997 DOI: 10.3389/fonc.2021.769036] [Reference Citation Analysis]
3 Nguyen ND, Yu M, Reddy VY, Acevedo-Diaz AC, Mesarick EC, Abi Jaoude J, Yuan M, Asara JM, Taniguchi CM. Comparative Untargeted Metabolomic Profiling of Induced Mitochondrial Fusion in Pancreatic Cancer. Metabolites 2021;11:627. [PMID: 34564443 DOI: 10.3390/metabo11090627] [Reference Citation Analysis]